International Journal of Stroke: Oral Anticoagulants and DOAC–Antiplatelet Therapy Are Associated with Increased Major Bleeding Risk
International Journal of Stroke shared a post on X about a recent article, by Sohei Yoshimura, published in SAGE Publishing, adding:
”Study finds oral anticoagulant alone and DOAC with antiplatelet therapy were associated with higher risks of major bleeding events than single antiplatelet therapy.”
Title: Long-term risk of bleeding events in patients taking antithrombotic agents for cerebrovascular or cardiovascular disease
Authors: Sohei Yoshimura, Kaori Miwa, Masatoshi Koga, Kanta Tanaka, Yoshiki Yagita, Yoshinari Nagakane, Haruhiko Hoshino, Tadashi Terasaki, Masayuki Shiozawa, Yasuyuki Iguchi, Shuji Arakawa, Shigeru Fujimoto, Yasushi Okada, Masafumi Ihara, Shinichi Takahashi, Ryosuke Doijiri, Makoto Sasaki, Yusuke Yakushiji, Teruyuki Hirano, Kazunori Toyoda
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy